VC  Skyline Ventures

     Office Locations:

525 University Avenue, Suite 610
Palo Alto, CA 94301
Phone: 650-462-5800
Fax: 650-329-1090



  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Founded in 1997, Skyline Ventures specializes in hands-on investing in early stage healthcare companies. The firm's initial investment is usually made at the time of a company's first venture round. In October 2007, Skyline completed raising Skyline V, which has $350 million in committed capital. The firm in aggregate has approximately $800 million under management. Skyline Ventures targets investments of $15-35 million per portfolio investment over the life of the company. The firm focuses in all sectors of the healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research, and healthcare information technology. Historically, a majority of the firm's portfolio companies have been in the San Francisco Bay Area. However, Skyline has also made investments throughout the United States, including the traditional investment centers of Boston and San Diego, as well as Denver, the Midwest, and Florida.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Eric M. Gordon PhD Venture Partner
    John G. Freund MD Managing Director
    Stephen J. Hoffman MD Venture Partner
    Yasunori Kaneko MD Managing Director


    Portfolio companies include:

      AcelRx Pharmaceuticals
        web link

        web link

        web link

      Collegium Pharma
        web link

      Concert Pharmaceuticals
        web link

      Crescendo Bioscience
        web link

      Dicerna Pharmaceuticals
        web link

        web link

      Dow Pharmaceutical Sciences
        web link

      Genocea Biosciences
        web link

      Hansen Medical
        web link

      iBalance Medical
        web link

        web link

      Proteon Therapeutics
        web link

        web link

        web link

      Sutro Biopharma
        web link

      Tetraphase Pharmaceuticals
        web link

      Varian Medical Systems
        web link

        web link


    Recent News: